Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Portier

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Biometrics|March 1, 1987
Semiparametric analysis of tumor incidence rates in survival/sacrifice experimentsC J Portier, G E Dinse
Bulletin of Mathematical Biology|September 22, 2007
Replication potential of cells via the protein kinase C-MAPK pathway: application of a mathematical modelH A El-Masri, C J Portier
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 1998
Physiologically based pharmacokinetics model of primidone and its metabolites phenobarbital and phenylethylmalonamide in humans, rats, and miceH A El-Masri, C J Portier
Science (New York, N.Y.)|November 18, 1994
Risk from low-dose exposuresC J Portier, G W Lucier, L Edler
Mathematical Biosciences|July 1, 1991
The application of a multistage model that incorporates DNA damage and repair to the analysis of initiation/promotion experimentsA Kopp-Schneider, C J Portier, F Rippmann
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 2, 1998
Characterizing dose-response: I: Critical assessment of the benchmark dose conceptJ A Murrell, C J Portier, R W Morris
Environmental Health Perspectives|December 1, 1993
Using cell replication data in mathematical modeling in carcinogenesisC J Portier, A Kopp-Schneider, C D Sherman
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 1, 1994
The exact formula for tumor incidence in the two-stage modelA Kopp-Schneider, C J Portier, C D Sherman
Toxicology and Applied Pharmacology|November 14, 1997
A mathematical model of production, distribution, and metabolism of melatonin in mammalian systemsG M Blumenthal, M C Kohn, C J Portier
Biometrics|September 1, 1993
A measure of tumorigenic potency incorporating dose-response shapeK L Meier, A J Bailer, C J Portier
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Biometrics|March 1, 1987
Semiparametric analysis of tumor incidence rates in survival/sacrifice experimentsC J Portier, G E Dinse
Bulletin of Mathematical Biology|September 22, 2007
Replication potential of cells via the protein kinase C-MAPK pathway: application of a mathematical modelH A El-Masri, C J Portier
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 1998
Physiologically based pharmacokinetics model of primidone and its metabolites phenobarbital and phenylethylmalonamide in humans, rats, and miceH A El-Masri, C J Portier
Science (New York, N.Y.)|November 18, 1994
Risk from low-dose exposuresC J Portier, G W Lucier, L Edler
Mathematical Biosciences|July 1, 1991
The application of a multistage model that incorporates DNA damage and repair to the analysis of initiation/promotion experimentsA Kopp-Schneider, C J Portier, F Rippmann
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 2, 1998
Characterizing dose-response: I: Critical assessment of the benchmark dose conceptJ A Murrell, C J Portier, R W Morris
Environmental Health Perspectives|December 1, 1993
Using cell replication data in mathematical modeling in carcinogenesisC J Portier, A Kopp-Schneider, C D Sherman
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 1, 1994
The exact formula for tumor incidence in the two-stage modelA Kopp-Schneider, C J Portier, C D Sherman
Toxicology and Applied Pharmacology|November 14, 1997
A mathematical model of production, distribution, and metabolism of melatonin in mammalian systemsG M Blumenthal, M C Kohn, C J Portier
Biometrics|September 1, 1993
A measure of tumorigenic potency incorporating dose-response shapeK L Meier, A J Bailer, C J Portier
Pageof 9